A detailed history of Itau Unibanco Holding S.A. transactions in Incyte Corp stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 974 shares of INCY stock, worth $69,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
974
Previous 596 63.42%
Holding current value
$69,202
Previous $36,000 77.78%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$57.33 - $68.61 $21,670 - $25,934
378 Added 63.42%
974 $64,000
Q2 2024

Aug 13, 2024

BUY
$51.18 - $63.75 $30,503 - $37,995
596 New
596 $36,000
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $21,229 - $26,125
407 Added 56.06%
1,133 $71,000
Q3 2023

Nov 14, 2023

SELL
$57.77 - $65.93 $173 - $197
-3 Reduced 0.41%
726 $41,000
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $182 - $226
-3 Reduced 0.41%
729 $45,000
Q1 2023

May 12, 2023

SELL
$70.23 - $86.01 $210 - $258
-3 Reduced 0.41%
732 $52,000
Q4 2022

Feb 09, 2023

SELL
$67.18 - $84.11 $1,746 - $2,186
-26 Reduced 3.42%
735 $59,000
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $50,362 - $63,056
761 New
761 $51,000
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $99,228 - $119,804
-1,503 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $36,990 - $43,280
584 Added 63.55%
1,503 $111,000
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $16,000 - $19,576
233 Added 33.97%
919 $63,000
Q2 2021

Aug 17, 2021

BUY
$79.87 - $87.53 $54,790 - $60,045
686 New
686 $58,000
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $23,299 - $30,534
-319 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $23,229 - $27,599
319 New
319 $27,000
Q1 2018

May 14, 2018

SELL
$83.06 - $100.98 $17,774 - $21,609
-214 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $23,358 - $29,589
214
214 $79,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.